Lasa Supergenerics (NSE:LASA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


NSE:LASA Lasa Supergenerics Ltd NSE:LASA
46 GF Score
Price ₹7.60
GF Value ₹4.36
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Lasa Supergenerics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

NSE:LASA vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lasa Supergenerics Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Lasa Supergenerics's Margin of Safety % (DCF FCF Based) falls into.


NSE:LASA
46GF Score
Lasa Supergenerics Ltd NSE:LASA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.60 is trading 74.3% above its estimated GF Value™ of ₹4.36. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹4.36 vs. price of ₹7.60 (74.3% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lasa Supergenerics Business Description

Other Exchanges 540702:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
46GF Score

Get the complete analysis for NSE:LASA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.60
Price
₹4.36
GF Value